![U.S. producer prices rise at hotter-than-anticipated rate in January](https://i-invdn-com.investing.com/news/Inflationretailsales_150x108_S_1665846370.jpg)
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1051 | 1029 | 1097 | 1008 | 1043 | 1478 |
Fund Return | 5.11% | 2.91% | 9.73% | 0.26% | 0.84% | 3.99% |
Place in category | - | - | - | - | - | - |
% in Category | - | - | - | - | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Trimark Fund SC | 3.94B | 4.86 | 10.47 | 8.67 | ||
Trimark Fund Series F | 3.94B | 4.92 | 11.26 | 9.29 | ||
Trimark Fund Series P | 3.94B | 4.82 | 9.98 | 8.14 | ||
Trimark Global Fundamental Eq F | 1.39B | 6.09 | 6.85 | 8.74 | ||
Trimark Global Fundam Eq Sr | 1.39B | 5.97 | 5.24 | 7.27 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Trimark Europlus Series F | 194.47M | 5.22 | 1.46 | 5.05 | ||
Trimark Europlus | 194.47M | 5.07 | -0.32 | 3.51 | ||
BMO European Advisor | 99.05M | 7.24 | 10.95 | 6.62 | ||
Invesco European Growth Class F | 12.23M | 5.15 | 4.69 | 4.83 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 3.77 | 570.3 | -2.63% | |
Investor B | SE0015811963 | 3.57 | 320.6 | +1.52% | |
Relx | GB00B2B0DG97 | 3.17 | 4,129.00 | +0.10% | |
Deutsche Boerse | DE0005810055 | 2.69 | 247.150 | +0.80% | |
IG Group | GB00B06QFB75 | 2.68 | 973.75 | -0.99% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Neutral |
Summary | Strong Buy | Strong Buy | Neutral |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review